United Kingdom vs World: Access to anti-retroviral drugs, female (%)
United Kingdom
96.0%
in 2023
World
83.0%
in 2024
United Kingdom rank
14th
World rank
15th
Access to anti-retroviral drugs, female (%) over time
- United Kingdom
- World
How they compare
United Kingdom currently reports 96.0% against 83.0% in World, a difference of 13.0%.
That makes United Kingdom's figure about 1.2 times World's.
Across all 8 years both countries report, United Kingdom has been ahead every year.
United Kingdom ranks 14th and World ranks 15th of 141 countries.
United Kingdom has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | United Kingdom | World | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.0% | 64.8% | 23.2% | United Kingdom |
| 2020s | 90.8% | 77.0% | 13.8% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, United Kingdom or World?
- United Kingdom, at 96.0% against 83.0% in World as of 2023.
- What is the difference in access to anti-retroviral drugs, female between United Kingdom and World?
- 13.0%, with United Kingdom ahead.
- How many years of comparable data are there for United Kingdom and World?
- 8 years are reported by both, from 2016 to 2023.
- How do United Kingdom and World rank globally for access to anti-retroviral drugs, female?
- United Kingdom ranks 14th and World ranks 15th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.